PledPharma: PledPharma AB PledPharma applies for an Orphan Drug Designation ODD in the US for Aladote

Stockholm December 24 2018. PledPharma AB publ announces that the company has filed an application for an Orphan Drug Designation ODD to the US FDA for the drug candidate Aladote developed t...